By Lily Cao, MD
Peer Reviewed
A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic Steatohepatitis [1]
Nonalcoholic steatohepatitis (NASH) is commonly diagnosed in primary care. We often counsel patients on diet and exercise, recommend vaccinations, and encourage …